Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancer Research|November 5, 2002
Enzyme-activated Prodrug Therapy Enhances Tumor-specific Replication of Adenovirus VectorsKathrin M Bernt, Dirk S Steinwaerder, Shaoheng Ni, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 20, 2004
A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastasesPavel Sova, Xiao-Wei Ren, Shaoheng Ni, et al.Journal of Virology|March 30, 2005
Development and assessment of human adenovirus type 11 as a gene transfer vectorDaniel Stone, Shaoheng Ni, Zong-Yi Li, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite proteinRobert Strauss, Andreas Hüser, Shaoheng Ni, et al.Journal of Virology|October 9, 2002
A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replicationKathrin Bernt, Min Liang, Xun Ye, et al.Biochemical and Biophysical Research Communications|July 25, 2003
Insulation from viral transcriptional regulatory elements enables improvement to hepatoma-specific gene expression from adenovirus vectorsXun Ye, Min Liang, Xia Meng, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2002
Dimerizer-induced proliferation of genetically modified hepatocytesZong-Yi Li, Kevin Otto, Robert E Richard, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 8, 2006
Evaluation of adenovirus vectors containing serotype 35 fibers for vaccinationNelson DiPaolo, Shaoheng Ni, Anuj Gaggar, et al.Cancer Research|June 19, 2007
Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responsesSebastian Tuve, Bing-Mae Chen, Ying Liu, et al.Plos One|June 19, 2008
Directed evolution generates a novel oncolytic virus for the treatment of colon cancerIrene Kuhn, Paul Harden, Maxine Bauzon, et al.Pageof 3